Pfizer COVID-19 vaccine appointments are available to our patients. Sign up for Connect today to schedule your vaccination. Continue your routine care with us by scheduling an in-person appointment or Video Visit.
Study Status: 
Study Description: 


Study Name: BioCardia

Study Objective: To evaluate safety/efficacy of CardiAMP cell therapy system in patients with post MI HF.

Key Inclusion Criteria:

  • Previous MI (> 6 months)  
  • EF ≥ 20% and ≤ 40% by echo
  • On stable evidence-based medical and device therapy for HF or post-infarction left ventricular dysfunction

Key Exclusion Criteria:

  • GFR < 30
  • Have a mechanical aortic valve or heart  constrictive device
  • AS or AI > 2+
  • CHB or QTc interval >550 ms                          
Principal Investigator: 
Maria Karas, MD

PI: Maria Karas, MD (646) 962 5555

RC:  Katelyn Bastert,  (212) 746 2698

Make an Appointment

(646) 962-5558

Weill Cornell Medicine
Division of Cardiology

520 East 70th Street
Starr 443
New York, NY 10021

1305 York Avenue, 8th Floor
New York, NY 10021